Clinical research can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participa…

Glioblastoma Multiforme

~Estimated

~$10 – $1,050

Power Life Sciences Inc.NCT05958485

Phase 1

A Multi-Center Pilot/Phase I and Phase II Clinical Trial of NG101m Adjuvant Therapy in Newly Diagnosed Glioblastoma Patients

The purpose of this clinical trial is to evaluate the addition of NG101m adjuvant therapy to standard of care treatment of glioblastoma multiforme. All subject…

Glioblastoma Multiforme

~Estimated

~$10 – $7,500

NeuGATE TheranosticsNCT04373785

Phase 1

A Prospective, Open-Label, Single-Arm Pilot Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

This will be a prospective, open-label, single-arm pilot study to investigate the safety and efficacy of Bevacizumab (BEV) in combination with microbubble (MB)…

Glioblastoma MultiformeGlioblastomaGlioma+3 more

~Estimated

~$10 – $8,750

NaviFUS CorporationNCT06329570

Phase 1

Phase I Study of Replication-Competent Adenovirus-Mediated Double Suicide Gene Therapy With Stereotactic Radiosurgery in Patients With Recurrent or Progressive High Grade Astrocytomas

The primary goal of this Phase I study is to determine the maximum tolerated dose of oncolytic adenovirus mediated double suicide-gene therapy in combination w…

Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more

~Estimated

~$10 – $6,250

Henry Ford Health SystemNCT05686798

← PreviousPage 5 of 5Next →